Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected price increase of over 15% in the next 6-12 months [5][12]. Core Insights - In 2025, the company achieved a revenue of 3.66 billion RMB, a year-on-year increase of 9.7%, with a gross profit of 1.86 billion RMB, up 18.9%. The net profit after deducting non-recurring items was 680 million RMB, reflecting a significant growth of 44.5% [2]. - The semiconductor materials segment generated 2.09 billion RMB in revenue, marking a 37.3% increase and surpassing 50% of total revenue for the first time. The CMP polishing pads contributed 1.09 billion RMB, growing by 52.3% [3]. - The company expects a net profit of 240 to 260 million RMB for Q1 2026, representing a year-on-year growth of 70.2% to 84.4% [2]. Revenue and Profit Forecast - Projected revenues for 2026, 2027, and 2028 are 4.14 billion RMB, 4.83 billion RMB, and 5.58 billion RMB, respectively, with growth rates of 13.0%, 16.8%, and 15.5% [5]. - The forecasted net profits for the same years are 1.01 billion RMB, 1.31 billion RMB, and 1.65 billion RMB, with respective growth rates of 40.0%, 30.3%, and 25.9% [5]. Acquisition Plans - The company plans to acquire 70% of Haofei New Materials, entering the lithium battery binder and dispersant market. Haofei's revenue for the first 11 months of 2025 was approximately 480 million RMB, with an overall valuation of 900 million RMB, corresponding to a P/E ratio of no more than 10 times [4].

Investment Rating - The report maintains a "Buy" rating for Lianlian Digital, expecting a price increase of over 15% in the next 6-12 months [1]. Core Insights - Lianlian Digital reported a revenue of 1.733 billion HKD for 2025, representing a year-on-year growth of 31.9%. The net profit reached 1.664 billion HKD, marking a turnaround from a loss in the previous year [1]. - The company's gross profit was 873 million HKD, with a gross margin of 50.4%, slightly down by 1.5 percentage points due to significant growth in lower-margin virtual card services [1]. - The global payment, domestic payment, and value-added services segments saw revenue growth of 29.3%, 18.3%, and 81.2% respectively, contributing 60%, 23%, and 15% to total revenue [1]. Business Segment Analysis Global Payment Business - In 2025, the global payment business generated 1.045 billion HKD, a 29.3% increase year-on-year, with a gross margin of 72.3%, up by 0.3 percentage points. The total payment volume (TPV) surged by 60.7% to 452.4 billion HKD, with a slight decrease in the comprehensive service fee rate to 0.23% [2]. - The company holds 66 payment licenses globally, covering 100 countries and regions, and supports over 130 currencies, positioning it for continued growth [2]. Domestic Payment Business - The domestic payment business achieved a revenue of 405 million HKD, reflecting an 18.3% year-on-year growth, with a gross margin of 23.0%, up by 3.3 percentage points. This growth is attributed to a strategic focus on high-value services for Chinese enterprises going global [2]. Value-Added Services - Revenue from value-added services reached 265 million HKD, showing a significant growth of 81.2%. However, the gross margin decreased by 11.9 percentage points to 7.2%, primarily due to the rapid growth of low-margin virtual card services [2]. Financial Forecast and Valuation - The report anticipates that the growth in TPV, improvement in gross margins, and strong momentum in value-added services will support Lianlian Digital's performance in 2025. The company is expected to achieve profitability in 2026 [3]. - Long-term prospects are bolstered by the company's licensing advantages, with both cross-border and domestic payment TPV expected to benefit from increasing digital payment demand. Projected sales per share (SPS) for 2026-2028 are 1.51, 1.86, and 2.20 HKD, with corresponding price-to-sales (P/S) ratios of 2.5, 2.1, and 1.8 [3].

1. Report Industry Investment Rating - No information provided in the given content 2. Core Viewpoints of the Report - As of March 22, 2026, the model recommends investing in non - ferrous metals, media, communication, steel, non - bank finance, and pharmaceutical biology, with marginal increases in non - ferrous metals, steel, and pharmaceutical biology. Non - bank finance, steel, and communication are mainly driven by expected boosts, while non - ferrous metals, media, and pharmaceutical biology are mainly driven by price - volume reversals and capital flows [2] - The industry rotation model assesses market micro - structure from fundamental, price - volume, and sentiment dimensions, and constructs a strategy using 7 relatively effective factors [2] 3. Summary by Relevant Catalogs 3.1 Industry Rotation Model and Recommended Industries - The industry rotation model analyzes from three dimensions: fundamentals, price - volume, and sentiment. It back - tests original factors bi - weekly and expands price - volume factors from multiple dimensions, ultimately selecting 7 factors to build a strategy [2] - Recommended industries are non - ferrous metals, media, communication, steel, non - bank finance, and pharmaceutical biology, with marginal increases in non - ferrous metals, steel, and pharmaceutical biology [2] 3.2 Industry ETF Portfolio - The industry ETF portfolio includes Southern China Securities Shenwan Non - Ferrous Metals ETF, GF China Securities Media ETF, Guotai China Securities All - Index Communication Equipment ETF, Guotai China Securities Steel ETF, E Fund CSI 300 Non - Bank Financial ETF, and E Fund CSI 300 Medical and Health ETF [4] - Details of each ETF, such as weight, year - end scale, institutional investors, trading volume, and returns, are provided. For example, the Southern China Securities Shenwan Non - Ferrous Metals ETF has a weight of 16.67%, a year - end scale of 20.591 billion yuan, and a one - year return of 77.03% [5] 3.3 Performance of the Industry Rotation Strategy - The industry rotation strategy declined 1.18% in the past two weeks, with an excess return of 3.18%. The excess return in the past year was 20.68%, the Sharpe ratio was 1.93, and the Calmar ratio was 3.83 [5][7] 3.4 Strategy/Composite Factor Back - testing Results - Different factors (price - volume, fundamental, and sentiment) have different IC means, IC standard deviations, ICIRs, and frequencies of IC>0. For example, the成交均价因子 has an IC mean of 4.02% and an ICIR of 15.14% [10] - After optimization, the composite factor has an IC mean of 7.81%, an ICIR of 32.49%, and a frequency of IC>0 of 46.64% [10]

Investment Rating - The report maintains a "Buy" rating for the company, anticipating significant growth in the coming years [4]. Core Insights - The company reported a revenue of 35.35 billion RMB for 2025, reflecting a year-on-year increase of 3.3%, and a net profit attributable to shareholders of 2.85 billion RMB, up 18.1% year-on-year [1]. - The cement business in Africa continues to thrive, contributing significantly to growth, with revenue reaching 21.29 billion RMB, a 13.3% increase year-on-year, and a gross margin of 32.7%, up 9.4 percentage points [2]. - The company has successfully integrated its aggregate and concrete businesses, achieving revenues of 5.483 billion RMB and 7.183 billion RMB respectively, although these segments saw declines of 2.82% and 14.65% year-on-year [3]. - The company has launched an incentive plan for H shares, aiming to enhance management motivation and performance [3]. Financial Projections - The projected net profits for 2026, 2027, and 2028 are 3.64 billion RMB, 3.97 billion RMB, and 4.23 billion RMB respectively, with growth rates of 28%, 9%, and 6% [4]. - The estimated price-to-earnings (P/E) ratios for the same years are 11.5, 10.5, and 9.9 [4]. Business Performance - In Q4 2025, the company achieved a revenue of 10.32 billion RMB, marking an 8.6% increase year-on-year, although the net profit showed a decline of 33.5% [1]. - The company’s cement and clinker sales reached 61.96 million tons, a 2.8% increase year-on-year, with domestic sales declining by 5% while overseas sales surged by 25% [2].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected price increase of over 15% in the next 6-12 months [4]. Core Insights - The company reported a revenue of 7.731 billion yuan for 2025, representing a year-on-year growth of 16.5%. The net profit attributable to shareholders was 1.344 billion yuan, up 86.2% year-on-year, with adjusted net profit at 1.280 billion yuan, reflecting a 27.1% increase [2]. - The company has achieved significant growth in its core business segments, particularly in neuroscience and oncology, with the neuroscience segment generating 2.753 billion yuan in revenue, a 26.6% increase year-on-year, and the oncology segment seeing a 53.0% increase to 1.987 billion yuan [2][3]. - The company has successfully licensed four pipeline products since 2025, generating substantial milestone payments and validating its R&D platform's value [3]. Financial Performance - The projected net profits for 2026, 2027, and 2028 are 1.608 billion yuan, 1.890 billion yuan, and 2.134 billion yuan, respectively, with growth rates of 19.6%, 17.6%, and 12.9% [4]. - The earnings per share (EPS) are expected to be 0.62 yuan, 0.73 yuan, and 0.82 yuan for the years 2026, 2027, and 2028, respectively, with corresponding price-to-earnings (P/E) ratios of 18, 16, and 14 [4]. - The company’s revenue is projected to grow from 7.731 billion yuan in 2025 to 10.036 billion yuan in 2026, reflecting a growth rate of 29.8% [9].

Investment Rating - The report maintains a "Buy" rating for the company, anticipating significant growth in the upcoming years [4]. Core Insights - The company reported a revenue of 35.35 billion RMB for 2025, reflecting a year-on-year increase of 3.3%, and a net profit attributable to shareholders of 2.85 billion RMB, up 18.1% year-on-year [1]. - The cement business in Africa continues to thrive, contributing significantly to growth, with revenue reaching 21.29 billion RMB, a 13.3% increase year-on-year, and a gross margin of 32.7%, up 9.4 percentage points [2]. - The company has successfully integrated its aggregate and concrete businesses, achieving revenues of 5.483 billion RMB and 7.183 billion RMB respectively, although these figures represent declines of 2.82% and 14.65% year-on-year [3]. - The company has launched an incentive plan for H-shares, aiming to enhance management motivation and performance [3]. Financial Projections - The projected net profits for 2026, 2027, and 2028 are 3.64 billion RMB, 3.97 billion RMB, and 4.23 billion RMB respectively, with growth rates of 28%, 9%, and 6% [4]. - The expected price-to-earnings (P/E) ratios for the same years are 11.5, 10.5, and 9.9 [4]. Business Performance - In Q4 2025, the company achieved a revenue of 10.32 billion RMB, marking an 8.6% increase year-on-year, although the net profit showed a decline of 33.5% [1]. - The company’s cement and clinker sales reached 61.96 million tons, a 2.8% increase year-on-year, with domestic sales declining by 5% while overseas sales surged by 25% [2].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected price increase of over 15% in the next 6-12 months [4][13]. Core Insights - In 2025, the company achieved revenue of 302.3 billion RMB, a year-on-year increase of 5.7%, and a net profit attributable to shareholders of 19.6 billion RMB, up 4.4% year-on-year [2]. - The company's domestic revenue grew despite a decline in the overall home appliance market, driven by digital inventory and marketing transformations [2][3]. - The company’s overseas revenue increased by 8.2% in 2025, outperforming the global market growth of 3.3% [3]. - The gross margin for 2025 was 26.7%, a decrease of 1.1 percentage points from the previous year, attributed to intensified domestic competition and rising raw material costs [3]. Summary by Sections Performance Review - In Q4 2025, the company reported revenue of 68.3 billion RMB, a decline of 6.7% year-on-year, and a net profit of 2.2 billion RMB, down 39.2% year-on-year [2]. Operational Analysis - The company focused on AI technology to enhance brand and product upgrades, resulting in an 8% increase in retail sales for the Haier brand [2]. - The Casarte brand continued to lead in the high-end market, achieving double-digit revenue growth [2]. - The Leader brand's revenue surpassed 10 billion RMB for the first time, growing by 30% [2]. Profitability and Cost Management - The company’s operating expenses were managed effectively, with sales expenses optimized through digital transformation, while management expenses increased due to one-time costs in the European market [3]. - The company is expected to achieve net profits of 20.9 billion RMB, 22.7 billion RMB, and 24.6 billion RMB for 2026, 2027, and 2028, respectively, with growth rates of 6.7%, 9.0%, and 8.3% [4]. Financial Projections - Revenue projections for the next three years are 317.2 billion RMB for 2026, 333.0 billion RMB for 2027, and 351.3 billion RMB for 2028, with growth rates of 4.9%, 4.98%, and 5.51% respectively [10].

Investment Rating - The report maintains a "Buy" rating for the company, with expected revenue growth and profit increases in the coming years [5]. Core Insights - The company reported a revenue of 14.355 billion RMB for 2025, representing a year-on-year growth of 22.59%, and a net profit of 1.471 billion RMB, up 20.48% year-on-year [2]. - The company's perception and intelligent manufacturing business has solidified its leading position in the domestic new energy and intelligent connected vehicle market, achieving a market share of 70% [3]. - The connection business has seen significant growth, with a year-on-year increase of 53.4%, becoming the main driver of the company's performance [3]. - The company has introduced leading technologies in optical modules, which are expected to benefit from the domestic AI computing power construction starting in 2026 [4]. Summary by Sections Performance Review - In Q4 2025, the company reported revenue of 3.317 billion RMB, a year-on-year increase of 22.50%, but a quarter-on-quarter decrease of 2.70%. The net profit for the same quarter was 149 million RMB, down 47.21% year-on-year and 63.55% quarter-on-quarter [2]. Operational Analysis - The perception business generated 4.03 billion RMB in revenue, growing 9.8% year-on-year. The intelligent manufacturing business revenue was approximately 3.64 billion RMB, with 88% of orders coming from high-end manufacturing sectors like new energy vehicles and ships [3]. - The gross margin for optical devices improved to 13.3%, an increase of 4.85 percentage points year-on-year, attributed to the product structure shifting towards high-end products [3]. Forward-Looking Layout - The company has launched several advanced optical engine solutions, including 1.6T 3nm FRO/LRO and 3.2T NPO, which are expected to meet the growing demand for high-capacity, long-distance transmission in data centers and backbone networks [4]. Profit Forecast and Valuation - Projected revenues for 2026, 2027, and 2028 are 22.302 billion RMB, 30.859 billion RMB, and 37.682 billion RMB, respectively. Corresponding net profits are expected to be 2.225 billion RMB, 2.506 billion RMB, and 2.823 billion RMB [5].

Investment Rating - The report maintains a "Buy" rating for the company, indicating an expected price increase of over 15% in the next 6-12 months [5][13]. Core Insights - In 2025, the company achieved a revenue of 3.696 billion RMB, representing a year-on-year growth of 31.18%. The net profit attributable to shareholders was 1.031 billion RMB, up 24.61% year-on-year [2]. - The approval of new indications for Pegbivac, aimed at achieving clinical cure for chronic hepatitis B, has solidified its position as a leading antiviral treatment, contributing to a revenue of 3.091 billion RMB in 2025, a growth of 26.34% [3]. - The successful commercialization of the long-acting growth hormone "Yipeisheng" is expected to create a second growth curve for the company, with the endocrine segment generating 256 million RMB in revenue in 2025 [3]. - The company is expanding its core technology platforms in innovative drug delivery and nucleic acid drug modification, with a robust pipeline of innovative drugs in various therapeutic areas [4]. Financial Summary - The company is projected to achieve net profits of 1.314 billion RMB (+27%), 1.642 billion RMB (+25%), and 1.965 billion RMB (+20%) for the years 2026 to 2028, respectively. The corresponding EPS is expected to be 3.22 RMB, 4.02 RMB, and 4.82 RMB [5][10]. - The revenue growth rates are forecasted to decline gradually from 26.19% in 2026 to 15.24% in 2028, reflecting a maturing growth phase [10]. - The company's P/E ratios are projected to decrease from 21 in 2026 to 14 in 2028, indicating a potential increase in valuation attractiveness over time [5].

Investment Rating - The report maintains a "Buy" rating for the company, with expected net profit growth of 6.7% in 2026, 9.0% in 2027, and 8.3% in 2028, corresponding to a PE valuation of 10.4, 9.5, and 8.8 times respectively [4] Core Insights - The company achieved a revenue of 302.3 billion RMB in 2025, a year-on-year increase of 5.7%, and a net profit attributable to shareholders of 19.6 billion RMB, up 4.4% year-on-year. However, Q4 2025 saw a revenue decline of 6.7% and a net profit drop of 39.2% year-on-year [2] - The company successfully implemented digital inventory and marketing transformations, resulting in domestic revenue growth despite a 4.3% decline in the overall Chinese home appliance market [2] - The company’s overseas revenue grew by 8.2% in 2025, outperforming the global core home appliance retail market, which grew by 3.3% [3] - The company’s gross margin decreased to 26.7%, down 1.1 percentage points from the previous year, primarily due to intensified domestic competition and rising raw material costs [3] Summary by Sections Performance Review - In 2025, the company reported a revenue of 302.3 billion RMB, with a year-on-year growth of 5.7%, and a net profit of 19.6 billion RMB, reflecting a 4.4% increase [2] - Q4 2025 results showed a revenue of 68.3 billion RMB, down 6.7% year-on-year, and a net profit of 2.2 billion RMB, down 39.2% year-on-year [2] Operational Analysis - The company’s domestic revenue grew by 3.1% in 2025, driven by digital inventory and marketing initiatives, while the overall home appliance market saw a decline [2] - The company’s overseas revenue increased by 8.2%, with significant growth in emerging markets exceeding 24% [3] Profitability and Cost Structure - The gross margin for 2025 was 26.7%, a decrease attributed to increased competition and rising costs [3] - The company’s expense ratios for sales, management, R&D, and financial costs were 11.2%, 4.6%, 3.3%, and -0.02% respectively, with sales expenses optimized through digital transformation [3] Forecast and Valuation - Projected net profits for 2026, 2027, and 2028 are 20.9 billion RMB, 22.7 billion RMB, and 24.6 billion RMB, with respective growth rates of 6.7%, 9.0%, and 8.3% [4] - The current stock price corresponds to PE ratios of 10.4, 9.5, and 8.8 for the years 2026, 2027, and 2028 [4]